These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9768618)

  • 1. Effective lysis of HIV-1-infected primary CD4+ T cells by a cytotoxic T-lymphocyte clone directed against a novel A2-restricted reverse-transcriptase epitope.
    Shankar P; Sprang H; Lieberman J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct; 19(2):111-20. PubMed ID: 9768618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.
    Yang OO; Kalams SA; Rosenzweig M; Trocha A; Jones N; Koziel M; Walker BD; Johnson RP
    J Virol; 1996 Sep; 70(9):5799-806. PubMed ID: 8709196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
    Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1.
    Tsomides TJ; Aldovini A; Johnson RP; Walker BD; Young RA; Eisen HN
    J Exp Med; 1994 Oct; 180(4):1283-93. PubMed ID: 7523570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of a small number of diverse epitopes dominates the cytotoxic T lymphocytes response to HIV type 1 in an infected individual.
    Lieberman J; Fabry JA; Fong DM; Parkerson GR
    AIDS Res Hum Retroviruses; 1997 Mar; 13(5):383-92. PubMed ID: 9075479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase.
    van der Burg SH; Klein MR; van de Velde CJ; Kast WM; Miedema F; Melief CJ
    AIDS; 1995 Feb; 9(2):121-7. PubMed ID: 7536421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic T lymphocytes from HIV-1 seropositive individuals recognize immunodominant epitopes in Gp160 and reverse transcriptase.
    Lieberman J; Fabry JA; Kuo MC; Earl P; Moss B; Skolnik PR
    J Immunol; 1992 May; 148(9):2738-47. PubMed ID: 1374097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creating HIV-1 reverse transcriptase cytotoxic T lymphocyte target structures by HLA-A2 heavy chain modifications.
    Dela Cruz CS; Tan R; Rowland-Jones SL; Barber BH
    Int Immunol; 2000 Sep; 12(9):1293-302. PubMed ID: 10967024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens.
    Jassoy C; Harrer T; Rosenthal T; Navia BA; Worth J; Johnson RP; Walker BD
    J Virol; 1993 May; 67(5):2844-52. PubMed ID: 7682629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific recognition of lamivudine-resistant HIV-1 by cytotoxic T lymphocytes.
    Schmitt M; Harrer E; Goldwich A; Bäuerle M; Graedner I; Kalden JR; Harrer T
    AIDS; 2000 Apr; 14(6):653-8. PubMed ID: 10807188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes.
    van Baalen CA; Guillon C; van Baalen M; Verschuren EJ; Boers PH; Osterhaus AD; Gruters RA
    Eur J Immunol; 2002 Sep; 32(9):2644-52. PubMed ID: 12207349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysis of CD4+ T cells expressing HIV-1 gag peptides by gag-specific CD8+ cytotoxic T cells.
    Salerno-Gonçalves R; Lu W; Achour A; Andrieu JM
    Immunol Lett; 1998 Dec; 64(2-3):71-7. PubMed ID: 9870657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.
    Klein MR; van der Burg SH; Hovenkamp E; Holwerda AM; Drijfhout JW; Melief CJ; Miedema F
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2191-201. PubMed ID: 9747728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope-enhanced conserved HIV-1 peptide protects HLA-A2-transgenic mice against virus expressing HIV-1 antigen.
    Okazaki T; Pendleton CD; Lemonnier F; Berzofsky JA
    J Immunol; 2003 Sep; 171(5):2548-55. PubMed ID: 12928405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of two epitopes on the dengue 4 virus capsid protein recognized by a serotype-specific and a panel of serotype-cross-reactive human CD4+ cytotoxic T-lymphocyte clones.
    Gagnon SJ; Zeng W; Kurane I; Ennis FA
    J Virol; 1996 Jan; 70(1):141-7. PubMed ID: 8523518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definition of two new epitopes on human immunodeficiency virus type 1 gag protein recognized by human CD8+ cytotoxic T lymphocyte clones.
    Kurane I; West K; Tuazon CU; Zeng W; Ennis FA
    J Clin Virol; 2003 May; 27(1):38-43. PubMed ID: 12727527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of a highly conserved region of human immunodeficiency virus type 1 gp120 by an HLA-Cw4-restricted cytotoxic T-lymphocyte clone.
    Johnson RP; Trocha A; Buchanan TM; Walker BD
    J Virol; 1993 Jan; 67(1):438-45. PubMed ID: 7677956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag.
    Littaua RA; Oldstone MB; Takeda A; Debouck C; Wong JT; Tuazon CU; Moss B; Kievits F; Ennis FA
    J Virol; 1991 Aug; 65(8):4051-6. PubMed ID: 1712857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.
    Bondurant KL; Crew MD; Santin AD; O'Brien TJ; Cannon MJ
    Clin Cancer Res; 2005 May; 11(9):3446-54. PubMed ID: 15867247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.